United States · Bill · HR
H.R. 2550 (118th)
Special Diabetes Program Reauthorization Act of 2023
Introduced
10 April 2023
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
27 May 2025
Summary
Special Diabetes Program Reauthorization Act of 2023 This bill extends funding through FY2028 for a program carried out by the National Institute of Diabetes and Digestive and Kidney Diseases that supports research on the prevention and cure of type 1 diabetes.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 10 April 2023
Introduced in House (PDF)
Introduced in House · EN · 10 April 2023
Introduced in House
summary · EN · 10 April 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/2550
- Open data entity: https://api.congress.gov/v3/bill/118/hr/2550